Phibro Animal Health Corporation (PAHC)
After hours:
| Previous close | 16.76 |
| Open | 16.95 |
| Bid | 17.02 x 100 |
| Ask | 17.14 x 200 |
| Day's range | 16.58 - 17.20 |
| 52-week range | 9.40 - 17.20 |
| Volume | |
| Avg. volume | 161,833 |
| Market cap | 691.396M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 46.14 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.48 (2.81%) |
| Ex-dividend date | 05 Mar 2024 |
| 1y target est | N/A |
- Business Wire
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
PARSIPPANY, N.J. & TEANECK, N.J., April 28, 2024--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
- Business Wire
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
TEANECK, N.J., April 18, 2024--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 8, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 9, 2024, at 9:00 AM Eastern Time.
- Business Wire
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
TEANECK, N.J., February 29, 2024--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference.
